Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03310346 · ClinicalTrials.gov registry record
Registry of Preterm Newborns With Severe Pulmonary Hypertension
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 232
- Enrollment target
NCT03310346: Completed study, sponsored by University of Colorado, Denver.
NCT03310346 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 232 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03310346 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 232 participants
- Enrollment target
Study Summary
The purpose of this prospective research registry is to collect data on treatment strategies and outcomes for premature newborns with severe pulmonary hypertension (PH).
Primary Outcome
Occurrence of death
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2022-07-02 |
What the finished NCT03310346 record still lists
NCT03310346 is an observational study that tracks outcomes without assigning an intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03310346 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03310346 about?
NCT03310346 is a clinical study titled "Registry of Preterm Newborns With Severe Pulmonary Hypertension". The purpose of this prospective research registry is to collect data on treatment strategies and outcomes for premature newborns with severe pulmonary hypertension (PH).
What is the current status of trial NCT03310346?
This trial is currently completed. The enrollment target is 232 participants. The study started on 2017-08-01. Estimated completion is 2022-07-02.
Who is sponsoring clinical trial NCT03310346?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01356290 · 232 participants · Phase 2
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- NCT04753359 · 232 participants · NA
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
- NCT04770870 · 232 participants · NA
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
- NCT05948943 · 232 participants · Phase 2
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI